PT787726E - Novo composto, processo para a sua producao e agente tumoral - Google Patents

Novo composto, processo para a sua producao e agente tumoral

Info

Publication number
PT787726E
PT787726E PT95920265T PT95920265T PT787726E PT 787726 E PT787726 E PT 787726E PT 95920265 T PT95920265 T PT 95920265T PT 95920265 T PT95920265 T PT 95920265T PT 787726 E PT787726 E PT 787726E
Authority
PT
Portugal
Prior art keywords
hydrogen atom
group
lower alkyl
production
alkyl group
Prior art date
Application number
PT95920265T
Other languages
English (en)
Inventor
Kyoji Tomita
Katsumi Chiba
Shigeki Kashimoto
Koh-Ichiro Shibamori
Yasunori Tsuzuki
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of PT787726E publication Critical patent/PT787726E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT95920265T 1994-06-14 1995-06-06 Novo composto, processo para a sua producao e agente tumoral PT787726E (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15657894 1994-06-14
JP19792194 1994-07-28
JP30691494 1994-11-15
JP33995694 1994-12-28
JP8170595 1995-03-13

Publications (1)

Publication Number Publication Date
PT787726E true PT787726E (pt) 2002-04-29

Family

ID=27524935

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95920265T PT787726E (pt) 1994-06-14 1995-06-06 Novo composto, processo para a sua producao e agente tumoral

Country Status (27)

Country Link
US (1) US5817669A (pt)
EP (1) EP0787726B1 (pt)
JP (1) JP3391796B2 (pt)
KR (1) KR100350921B1 (pt)
CN (1) CN1053668C (pt)
AT (1) ATE209645T1 (pt)
AU (1) AU679859B2 (pt)
BR (1) BR9508037A (pt)
CA (1) CA2192824C (pt)
CZ (1) CZ292631B6 (pt)
DE (1) DE69524251T2 (pt)
DK (1) DK0787726T3 (pt)
ES (1) ES2163512T3 (pt)
FI (1) FI112485B (pt)
HK (1) HK1000495A1 (pt)
HU (1) HU220072B (pt)
MX (1) MX9606331A (pt)
NO (1) NO307255B1 (pt)
NZ (1) NZ287139A (pt)
PL (1) PL181867B1 (pt)
PT (1) PT787726E (pt)
RO (1) RO117793B1 (pt)
RU (1) RU2151770C1 (pt)
SI (1) SI0787726T1 (pt)
SK (1) SK281341B6 (pt)
TW (1) TW319769B (pt)
WO (1) WO1995034559A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040041177A (ko) * 2001-09-26 2004-05-14 바이엘 파마슈티칼스 코포레이션 당뇨병 치료제로서의 1,6-나프티리딘 유도체
US6802423B2 (en) * 2002-02-20 2004-10-12 Trans Global Foods, Inc. Disposable food delivery apparatus
US7163948B2 (en) * 2003-04-07 2007-01-16 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
WO2005026147A1 (ja) * 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
DE10352979A1 (de) * 2003-11-13 2005-06-09 Merck Patent Gmbh Pyridopyrimidinone
PL2295056T3 (pl) * 2004-03-15 2016-07-29 Sunesis Pharmaceuticals Inc Zastosowanie SNS-595 do leczenia białaczki
AU2013201203C1 (en) * 2004-03-15 2015-04-23 Sumitomo Dainippon Pharma Co., Ltd. Sns-595 and methods of using the same
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
EP1926372A2 (en) * 2005-08-19 2008-06-04 Cylene Pharmaceuticals, Inc. HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
AU2006287149B2 (en) * 2005-09-02 2013-05-23 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
AU2013219242C1 (en) * 2005-09-02 2016-09-22 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
JP5374153B2 (ja) * 2005-09-02 2013-12-25 サネシス ファーマシューティカルズ， インコーポレイテッド 癌の治療のための（＋）−１，４−ジヒドロ−７−［（３ｓ，４ｓ）−３−メトキシ−４−（メチルアミノ）−１−ピロリジニル］−４−オキソ−１−（２−チアゾリル）−１，８−ナフチリジン−３−カルボン酸を使用する方法
US8580814B2 (en) * 2006-04-03 2013-11-12 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
CN104873502A (zh) * 2005-09-02 2015-09-02 逊尼希思制药公司 使用(+)-1,4-二氢-7-[(3s,4s)-3-甲氧基-4-(甲氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸治疗癌症的方法
TW200800983A (en) 2005-09-14 2008-01-01 Janssen Pharmaceutica Nv 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
US7642270B2 (en) 2005-09-14 2010-01-05 Janssen Pharmaceutica N.V. 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
JP2009507924A (ja) * 2005-09-14 2009-02-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ｃ−ｆｍｓキナーゼ阻害剤としての５−オキソ−５，８−ジヒドロ−ピリド−ピリミジン
US8124773B2 (en) 2006-06-12 2012-02-28 Sunesis Pharmaceuticals, Inc. 1,8-naphthyridine compounds for the treatment of cancer
WO2008016678A2 (en) * 2006-08-01 2008-02-07 Sunesis Pharmaceuticals, Inc. Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
HUE026693T2 (hu) * 2006-08-02 2016-07-28 Sunesis Pharmaceuticals Inc (+)-1,4-dihidro-7-[(3S,4S)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil) -1,8-naftiridin-3-karbonsav és cytarabin (Ara-C) kombinált alkalmazása leukémia kezelésére
MX2010004350A (es) * 2007-10-22 2010-05-19 Sunesis Pharmaceuticals Inc Metodos de uso del acido (+)-1,4-dihidro-7-[(3s,4s)]-3-metoxi-4-(m etilamino)-1-pirrolidinil-4-oxo-1-(2-tiazolil)-1, 8-naftiridina-3-carboxilico en terapias de combinacion.
WO2009075841A2 (en) * 2007-12-10 2009-06-18 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
AU2009335159B2 (en) 2008-12-31 2015-07-23 Sunesis Pharmaceuticals, Inc. Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
AU2010217796B2 (en) 2009-02-27 2015-04-30 Sunesis Pharmaceuticals, Inc. Methods of using SNS-595 for treatment of cancer subjects with reduced BRCA2 activity
UA110465C2 (en) 2009-09-04 2016-01-12 Sunesis Pharmaceutecals Inc Stable sns-595 composition
TW201120037A (en) * 2009-10-26 2011-06-16 Sunesis Pharmaceuticals Inc Compounds and methods for treatment of cancer
AU2012256237B2 (en) 2011-05-13 2017-01-05 Array Biopharma Inc. Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as TrkA kinase inhibitors
CN103497186B (zh) * 2013-09-24 2015-02-25 浙江司太立制药股份有限公司 含有烷氧亚氨基取代的萘啶酮羧酸衍生物及其制备方法
JP7518618B2 (ja) * 2017-03-24 2024-07-18 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
EP0154780B1 (en) * 1984-01-26 1990-04-11 Abbott Laboratories Quinoline antibacterial compounds
JPS61152682A (ja) * 1984-12-27 1986-07-11 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS61251667A (ja) * 1985-04-30 1986-11-08 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
PT82752B (pt) * 1985-06-13 1988-12-15 Schering Corp Processo para a preparacao de derivados policiclicos de quinolina, naftiridina e pirazinopiridina
EP0226624A1 (en) * 1985-06-14 1987-07-01 The Upjohn Company Cyclopentapyrazole and tetrahydroindazole compounds
JPS6233176A (ja) * 1985-08-05 1987-02-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP2704428B2 (ja) * 1988-06-15 1998-01-26 富山化学工業株式会社 キノロンカルボン酸誘導体またはその塩
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH06233176A (ja) * 1993-01-29 1994-08-19 Sony Corp ビデオカメラ

Also Published As

Publication number Publication date
HK1000495A1 (en) 2002-07-19
EP0787726A1 (en) 1997-08-06
MX9606331A (es) 1997-03-29
HU9603455D0 (en) 1997-02-28
EP0787726B1 (en) 2001-11-28
NO307255B1 (no) 2000-03-06
US5817669A (en) 1998-10-06
ES2163512T3 (es) 2002-02-01
FI112485B (fi) 2003-12-15
PL181867B1 (pl) 2001-09-28
HU220072B (hu) 2001-10-28
DE69524251T2 (de) 2002-07-11
SK157496A3 (en) 1997-08-06
AU679859B2 (en) 1997-07-10
KR100350921B1 (ko) 2002-11-18
RO117793B1 (ro) 2002-07-30
FI965020A (fi) 1996-12-16
DK0787726T3 (da) 2002-02-11
CA2192824C (en) 2006-11-07
DE69524251D1 (de) 2002-01-10
NO965305D0 (no) 1996-12-11
CN1053668C (zh) 2000-06-21
NZ287139A (en) 1997-07-27
EP0787726A4 (pt) 1997-08-06
SI0787726T1 (en) 2002-04-30
TW319769B (pt) 1997-11-11
CZ364396A3 (en) 1997-06-11
PL317726A1 (en) 1997-04-28
FI965020A0 (fi) 1996-12-13
JP3391796B2 (ja) 2003-03-31
WO1995034559A1 (fr) 1995-12-21
HUT75777A (en) 1997-05-28
CN1158614A (zh) 1997-09-03
NO965305L (no) 1997-02-04
ATE209645T1 (de) 2001-12-15
CZ292631B6 (cs) 2003-11-12
BR9508037A (pt) 1997-09-16
CA2192824A1 (en) 1995-12-21
SK281341B6 (sk) 2001-02-12
AU2576795A (en) 1996-01-05
RU2151770C1 (ru) 2000-06-27

Similar Documents

Publication Publication Date Title
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
FI892787A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
PL285247A1 (en) Method of obtaining n-(aryloalkyl) heteroarylopiperidnes and heteroarylopiperazines
PT80463B (pt) Processo de preparacao de 7-halo-7-desoxilincomicinas e de composicoes farmaceuticas contendo as mesmas
ES2118364T3 (es) Derivados de acido hidroxietilamino-sulfamico utiles como inhibidores de proteasas retroviricas.
SE8404712D0 (sv) Azole derivatives, process for their production compositions containing them and their use
ATE232528T1 (de) Pyrimidinylpyrazolderivate
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
PT99043A (pt) Processo para a preparacao de composicoes biocidas contendo derivados de 4,5-polimetileno-4-isotiazolin-3-onas
BR9104632A (pt) Composto,composicao farmaceutica,aplicacao do referido composto e processo para a preparacao do referido composto
PT971899E (pt) Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica.
EP1112998A4 (en) AMINE DERIVATIVES
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ES8506702A1 (es) Un derivado del acido furiloxazolilacetico
HU901377D0 (en) Process for preparation of carbamates
ATE74604T1 (de) Substituierte pyrimidochinoxaline.
EP0827961A4 (en) METHOD FOR PRODUCING BETA-LACTAM COMPOUNDS
DK0557519T3 (da) Fremgangsmåde til fremstilling af sulfonamidderivater af norbornan
PT84067B (pt) Processo de preparacao de novos derivados de pregnano
PT71432A (en) Clavulanic acid derivatives a process for their preparation and their use